Clinical Trials Browser

Withdrawn × Glioma × Immunotherapy, Adoptive × Clear all

NCT02575261 2020-07-16

CAR-T Cell Immunotherapy for EphA2 Positive Malignant Glioma Patients

Phase 1/2 Withdrawn

Glioma